287 related articles for article (PubMed ID: 17699770)
1. Sequential down-regulation of E-cadherin with squamous cell carcinoma progression: loss of E-cadherin via a prostaglandin E2-EP2 dependent posttranslational mechanism.
Brouxhon S; Kyrkanides S; O'Banion MK; Johnson R; Pearce DA; Centola GM; Miller JN; McGrath KH; Erdle B; Scott G; Schneider S; VanBuskirk J; Pentland AP
Cancer Res; 2007 Aug; 67(16):7654-64. PubMed ID: 17699770
[TBL] [Abstract][Full Text] [Related]
2. Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development.
Sung YM; He G; Fischer SM
Cancer Res; 2005 Oct; 65(20):9304-11. PubMed ID: 16230392
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development.
Sung YM; He G; Hwang DH; Fischer SM
Oncogene; 2006 Sep; 25(40):5507-16. PubMed ID: 16607275
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin receptor EP2 is responsible for cyclooxygenase-2 induction by prostaglandin E2 in mouse skin.
Ansari KM; Sung YM; He G; Fischer SM
Carcinogenesis; 2007 Oct; 28(10):2063-8. PubMed ID: 17277233
[TBL] [Abstract][Full Text] [Related]
5. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs.
Margulis A; Zhang W; Alt-Holland A; Crawford HC; Fusenig NE; Garlick JA
Cancer Res; 2005 Mar; 65(5):1783-91. PubMed ID: 15753375
[TBL] [Abstract][Full Text] [Related]
6. Deletion of prostaglandin E2 EP2 receptor protects against ultraviolet-induced carcinogenesis, but increases tumor aggressiveness.
Brouxhon S; Konger RL; VanBuskirk J; Sheu TJ; Ryan J; Erdle B; Almudevar A; Breyer RM; Scott G; Pentland AP
J Invest Dermatol; 2007 Feb; 127(2):439-46. PubMed ID: 16977324
[TBL] [Abstract][Full Text] [Related]
7. WOX1 is essential for UVB irradiation-induced apoptosis and down-regulated via translational blockade in UVB-induced cutaneous squamous cell carcinoma in vivo.
Lai FJ; Cheng CL; Chen ST; Wu CH; Hsu LJ; Lee JY; Chao SC; Sheen MC; Shen CL; Chang NS; Sheu HM
Clin Cancer Res; 2005 Aug; 11(16):5769-77. PubMed ID: 16115915
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumor growth and metastasis by depletion of vesicular sorting protein Hrs: its regulatory role on E-cadherin and beta-catenin.
Toyoshima M; Tanaka N; Aoki J; Tanaka Y; Murata K; Kyuuma M; Kobayashi H; Ishii N; Yaegashi N; Sugamura K
Cancer Res; 2007 Jun; 67(11):5162-71. PubMed ID: 17545595
[TBL] [Abstract][Full Text] [Related]
9. Diminished expression of C/EBPalpha in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPalpha in carcinoma cells inhibits proliferation.
Shim M; Powers KL; Ewing SJ; Zhu S; Smart RC
Cancer Res; 2005 Feb; 65(3):861-7. PubMed ID: 15705884
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression.
Llorens A; Rodrigo I; López-Barcons L; Gonzalez-Garrigues M; Lozano E; Vinyals A; Quintanilla M; Cano A; Fabra A
Lab Invest; 1998 Sep; 78(9):1131-42. PubMed ID: 9759657
[TBL] [Abstract][Full Text] [Related]
11. The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia.
Chang SH; Ai Y; Breyer RM; Lane TF; Hla T
Cancer Res; 2005 Jun; 65(11):4496-9. PubMed ID: 15930264
[TBL] [Abstract][Full Text] [Related]
12. Distinct P-cadherin expression in cultured normal human keratinocytes and squamous cell carcinoma cell lines.
Wakita H; Shirahama S; Furukawa F
Microsc Res Tech; 1998 Nov; 43(3):218-23. PubMed ID: 9840799
[TBL] [Abstract][Full Text] [Related]
13. Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion.
Klucky B; Mueller R; Vogt I; Teurich S; Hartenstein B; Breuhahn K; Flechtenmacher C; Angel P; Hess J
Cancer Res; 2007 Sep; 67(17):8198-206. PubMed ID: 17804733
[TBL] [Abstract][Full Text] [Related]
14. T-cadherin enhances cell-matrix adhesiveness by regulating beta1 integrin trafficking in cutaneous squamous carcinoma cells.
Mukoyama Y; Utani A; Matsui S; Zhou S; Miyachi Y; Matsuyoshi N
Genes Cells; 2007 Jun; 12(6):787-96. PubMed ID: 17573778
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 (PGE2) downregulates interleukin (IL)-1alpha-induced IL-6 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells.
Noguchi K; Maeda M; Ruwanpura SM; Ishikawa I
Oral Dis; 2005 May; 11(3):157-62. PubMed ID: 15888106
[TBL] [Abstract][Full Text] [Related]
16. Raf plus TGFbeta-dependent EMT is initiated by endocytosis and lysosomal degradation of E-cadherin.
Janda E; Nevolo M; Lehmann K; Downward J; Beug H; Grieco M
Oncogene; 2006 Nov; 25(54):7117-30. PubMed ID: 16751808
[TBL] [Abstract][Full Text] [Related]
17. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression.
Mauro L; Catalano S; Bossi G; Pellegrino M; Barone I; Morales S; Giordano C; Bartella V; Casaburi I; Andò S
Cancer Res; 2007 Apr; 67(7):3412-21. PubMed ID: 17409452
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion.
Portella G; Cumming SA; Liddell J; Cui W; Ireland H; Akhurst RJ; Balmain A
Cell Growth Differ; 1998 May; 9(5):393-404. PubMed ID: 9607560
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of PGE2 receptor EP2 in esophageal squamous cell carcinoma.
Kuo KT; Wang HW; Chou TY; Hsu WH; Hsu HS; Lin CH; Wang LS
Ann Surg Oncol; 2009 Feb; 16(2):352-60. PubMed ID: 19050969
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin promoter hypermethylation in preneoplastic and neoplastic skin lesions.
Chiles MC; Ai L; Zuo C; Fan CY; Smoller BR
Mod Pathol; 2003 Oct; 16(10):1014-8. PubMed ID: 14559984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
